Cargando…

SIOP Ependymoma I: Final results, long-term follow-up, and molecular analysis of the trial cohort—A BIOMECA Consortium Study

BACKGROUND: SIOP Ependymoma I was a non-randomised trial assessing event free and overall survival (EFS/OS) of non-metastatic intracranial ependymoma in children aged 3–21 years treated with a staged management strategy. A further aim was to assess the response rate (RR) of subtotally resected (STR)...

Descripción completa

Detalles Bibliográficos
Autores principales:	Ritzmann, Timothy A, Chapman, Rebecca J, Kilday, John-Paul, Thorp, Nicola, Modena, Piergiorgio, Dineen, Robert A, Macarthur, Donald, Mallucci, Conor, Jaspan, Timothy, Pajtler, Kristian W, Giagnacovo, Marzia, Jacques, Thomas S, Paine, Simon M L, Ellison, David W, Bouffet, Eric, Grundy, Richard G
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2022
Materias:	Clinical Investigations
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9159435/ https://www.ncbi.nlm.nih.gov/pubmed/35018471 http://dx.doi.org/10.1093/neuonc/noac012

Ejemplares similares

EPEN-04. SIOP EPENDYMOMA I: FINAL RESULTS, LONG TERM FOLLOW-UP AND MOLECULAR ANALYSIS OF THE TRIAL COHORT: A BIOMECA CONSORTIUM STUDY
por: A. Ritzmann, Timothy, et al.
Publicado: (2021)

EPEN-24. Biological markers of ependymoma in children and adolescents (BIOMECA): Systematic comparison of methods for the precise evaluation of biomarkers for ependymoma diagnosis and prognostication
por: Chapman, Rebecca, et al.
Publicado: (2022)

EPEN-24. SIOP EPENDYMOMA II: CENTRAL EPENDYMOMA MANAGEMENT ADVISORY GROUP – THE UK EXPERIENCE
por: Macarthur, Donald C, et al.
Publicado: (2020)

Optimizing biomarkers for accurate ependymoma diagnosis, prognostication, and stratification within International Clinical Trials: A BIOMECA study
por: Chapman, Rebecca J, et al.
Publicado: (2023)

EPEN-02. OPTIMISING BIOMARKERS FOR ACCURATE EPENDYMOMA DIAGNOSIS, PROGNOSTICATION AND STRATIFICATION WITHIN INTERNATIONAL CLINICAL TRIALS: A BIOMECA STUDY
por: Chapman, Rebecca J, et al.
Publicado: (2023)

Pediatric ependymomas: destined to recur?
por: Ritzmann, Timothy A, et al.
Publicado: (2021)

Phase II study of intravenous etoposide in patients with relapsed ependymoma (CNS 2001 04)
por: Apps, John R, et al.
Publicado: (2022)

Toward Improved Diagnosis Accuracy and Treatment of Children, Adolescents, and Young Adults With Ependymoma: The International SIOP Ependymoma II Protocol
por: Leblond, Pierre, et al.
Publicado: (2022)

EPEN-05. Adenosine receptor expression in paediatric ependymoma
por: Spanoudakis, Chelsea, et al.
Publicado: (2022)

Ependymomas
por: Bertero, Luca, et al.
Publicado: (2022)

IMMU-10. TUMOR ASSOCIATED MYELOID CELLS DRIVE THE IMMUNOBIOLOGY OF HIGH RISK PEDIATRIC EPENDYMOMA
por: Griesinger, Andrea, et al.
Publicado: (2022)

EPEN-08. THE TREM1 POSITIVE HYPOXIC MYELOID SUBPOPULATION IN POSTERIOR FOSSA EPENDYMOMA
por: Willard, Nicholas, et al.
Publicado: (2021)

EPEN-23. A COMPUTATIONAL ANALYSIS OF THE TUMOUR IMMUNE MICROENVIRONMENT IN PAEDIATRIC EPENDYMOMA
por: Ritzmann, Timothy, et al.
Publicado: (2020)

Molecular dissection of ependymomas
por: Pajtler, Kristian W., et al.
Publicado: (2015)

EPEN-07. A MULTICENTER STUDY OF POOR PROGNOSIS CHROMOSOME 1Q GAIN AND/OR 6Q LOSS IN POSTERIOR FOSSA A EPENDYMOMA SHOWS INCREASED PREVALENCE FROM 20% AT DIAGNOSIS TO 60% AT FIRST RECURRENCE
por: Donson, Andrew, et al.
Publicado: (2023)

The current consensus on the clinical management of intracranial ependymoma and its distinct molecular variants
por: Pajtler, Kristian W., et al.
Publicado: (2016)

EPEN-11. TUMOR DIFFERENTIATION IMPACTS THE BIOLOGY OF RECURRENCE IN CHILDHOOD POSTERIOR FOSSA EPENDYMOMA
por: Donson, Andrew, et al.
Publicado: (2021)

A role for ABCB1 in prognosis, invasion and drug resistance in ependymoma
por: Sabnis, Durgagauri H., et al.
Publicado: (2019)

Assessment of Cannabidiol and Δ9-Tetrahydrocannabiol in Mouse Models of Medulloblastoma and Ependymoma
por: Andradas, Clara, et al.
Publicado: (2021)

Multi-omic approach identifies hypoxic tumor-associated myeloid cells that drive immunobiology of high-risk pediatric ependymoma
por: Griesinger, Andrea M., et al.
Publicado: (2023)

Care of adolescents and young adults with cancer in Asia: results of an ESMO/SIOPE/SIOP Asia survey
por: Li, Chi Kong, et al.
Publicado: (2019)

Integrating Tenascin-C protein expression and 1q25 copy number status in pediatric intracranial ependymoma prognostication: A new model for risk stratification
por: Andreiuolo, Felipe, et al.
Publicado: (2017)

Gain of 1q As a Prognostic Biomarker in Wilms Tumors (WTs) Treated With Preoperative Chemotherapy in the International Society of Paediatric Oncology (SIOP) WT 2001 Trial: A SIOP Renal Tumours Biology Consortium Study
por: Chagtai, Tasnim, et al.
Publicado: (2016)

Limitations of current in vitro models for testing the clinical potential of epigenetic inhibitors for treatment of pediatric ependymoma
por: Rogers, Hazel Anne, et al.
Publicado: (2018)

Evaluation of the Perioperative and Postoperative Course of Surgery for Pineal Germinoma in the SIOP CNS GCT 96 Trial
por: Shabo, Ehab, et al.
Publicado: (2022)

Management of Wilms' tumor: NWTS vs SIOP
por: Bhatnagar, Sushmita
Publicado: (2009)

Current recommendations for cancer surveillance in Gorlin syndrome: a report from the SIOPE host genome working group (SIOPE HGWG)
por: Guerrini-Rousseau, L., et al.
Publicado: (2021)

EPEN-07. SINGLE-CELL RNA SEQUENCING IDENTIFIES A UNIQUE MYELOID SUBPOPULATION ASSOCIATED WITH MESENCHYMAL TUMOR SUBPOPULATION IN POOR OUTCOME PEDIATRIC EPENDYMOMA
por: Griesinger, Andrea, et al.
Publicado: (2021)

GCT-49. EVALUATION OF THE PERIOPERATIVE AND POSTOPERATIVE COURSE OF SURGERY OF PINEAL GERMINOMA ACCORDING TO THE SIOP CNS GCT 96 TRIAL
por: Shabo, Ehab, et al.
Publicado: (2020)

EPEN-47. PEDS: PEDIATRIC EPENDYMOMA DISCOVERY STUDY
por: Smith, Amy, et al.
Publicado: (2020)

LINC-10. SIOP PODC ADAPTED TREATMENT GUIDELINES FOR CRANIOPHARYNGIOMA IN LOW- AND MIDDLE-INCOME SETTINGS
por: amayiri, Nisreen, et al.
Publicado: (2020)

Supratentorial and spinal pediatric ependymomas display a hypermethylated phenotype which includes the loss of tumor suppressor genes involved in the control of cell growth and death
por: Rogers, Hazel A., et al.
Publicado: (2011)

Telomere maintenance and dysfunction predict recurrence in paediatric ependymoma
por: Tabori, U, et al.
Publicado: (2008)

The current status of treatment of Wilms’ tumor as per the SIOP trials
por: Godzinski, Jan
Publicado: (2015)

Challenges for children and adolescents with cancer in Europe: The SIOP-Europe agenda
por: Vassal, Gilles, et al.
Publicado: (2014)

MEDB-40. RUNNING FOR INCLUSION IN SIOPE PNET5 MB
por: Massimino, Maura, et al.
Publicado: (2022)

Expression alterations define unique molecular characteristics of spinal ependymomas
por: Lourdusamy, Anbarasu, et al.
Publicado: (2015)

EPEN-43. TARGETING INTRA-TUMOUR HETEROGENEITY IN PAEDIATRIC EPENDYMOMA: AN INTEGRATED OMICS STUDY TOWARDS PATIENT-TAILORED THERAPY
por: Pandele, Alina, et al.
Publicado: (2020)

Histopathological grading of pediatric ependymoma: reproducibility and clinical relevance in European trial cohorts
por: Ellison, David W, et al.
Publicado: (2011)

QOL-17. BIOLOGICAL CORRELATES OF QUALITY OF SURVIVAL AND NEUROCOGNITIVE OUTCOMES IN MEDULLOBLASTOMA; A META-ANALYSIS OF THE SIOP-UKCCSG-PNET3 AND HIT-SIOP-PNET4 TRIALS
por: Chevignard, Mathilde, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_gg7p7k0nvs2uckgvsnh4ebvf8n